Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Target of Rapamycin (mTOR) as Mediator of Exercise-induced Insulin Sensitivity Study

NCT05233722 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT05233722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Target of Rapamycin (mTOR) as Mediator of Exercise-induced Insulin Sensitivity Study
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Recruiting
Start date
February 10, 2022
Completion date
June 30, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin sensitivity